JW Lifescience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 15 shareholders own 45.88% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
44%	JW Holdings Corporation	6,806,168	₩84.7b	0%	no data
0.7%	Dimensional Fund Advisors LP	107,890	₩1.3b	8.5%	no data
0.63%	Jw Life Science Co. Ltd, Employee Stock Ownership Association	97,516	₩1.2b	0%	no data
0.15%	Eaton Vance Management	23,300	₩290.1m	0%	no data
0.12%	Midas Asset Management	17,936	₩223.3m	-3.54%	0.05%
0.1%	Kyung-Ha Lee	15,500	₩193.0m	0%	no data
0.074%	Lee Hyun Soon	11,500	₩143.2m	0%	no data
0.064%	Hi Asset Management Co., Ltd.	9,900	₩123.2m	0%	0.08%
0.039%	Acadian Asset Management LLC	6,000	₩74.7m	0%	no data
0.023%	Samsung Asset Management Company, Ltd.	3,619	₩45.1m	-3.72%	no data
0.014%	Jeong-Yeol Noh	2,104	₩26.2m	0%	no data
0.0073%	Mirae Asset Global Investments Co., Ltd.	1,130	₩14.1m	-33%	no data
0.006%	KB Asset Management Co., Ltd.	924	₩11.5m	-56%	no data
0.0027%	Hanwha Asset Management Co. Ltd.	415	₩5.2m	0%	no data
0.00036%	Korea Investment Management Co., Ltd.	55	₩694.0k	0%	no data